Nicholas Fernandez
Fortuna: 535 785 $ al 31/08/2026
Fortuna: 535 785 $ al 31/08/2026
Nicholas Fernandez is currently Independent Director at Liminatus Pharma, Inc. since 2025.
Mr. Fernandez is also Chief Financial Officer at JATT II Acquisition Corp., Amanat Acquisition Corp., and JATT III Acquisition Corp.
Mr. Fernandez was Independent Director at Iris Acquisition Corp.
Mr. Fernandez was Chief Operating & Financial Officer at Athanor Capital GP LLC.
Mr. Fernandez completed undergraduate studies at the State University of New York at Albany.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
2,3 % | 20/05/2026 | 50.000 ( 2,3 % ) | 534 500 $ | 31/08/2026 |
0,02 % | 02/07/2026 | 333 ( 0,02 % ) | 1 285 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|
| Empresas | Cargo | Fin |
|---|---|---|
Athanor Capital GP LLC
Athanor Capital GP LLC Financial ConglomeratesFinance Provides investment services | Director Financiero/CFO | - |
| LIMINATUS PHARMA, INC. | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
State University of New York at Albany
State University of New York at Albany Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Athanor Capital GP LLC
Athanor Capital GP LLC Financial ConglomeratesFinance Provides investment services | Finance |
Iris Acquisition Corp.
Iris Acquisition Corp. Financial ConglomeratesFinance Operates as blank check company | Finance |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.